OnEMI Technology IPO received a decent investor response with an overall subscription of 9.50 times, driven by strong participation from qualified institutional buyers
Applicants can check their OnEMI Technology IPO allotment status on the official NSE and BSE websites, as well as on the registrar's portal, Kfin Technologies
OnEMI Technology IPO comprises a combination of fresh issue of 49.7 million equity shares amounting to ₹850 crore and an OFS of 4.4 million equity shares amounting to ₹75.92 crore
OnEMI's unlisted shares were trading at ₹174.75 per share, commanding a grey market premium of ₹3.75, or 2.2 per cent, over the upper end of the IPO price band of ₹162 to ₹171
Om Power Transmission IPO received a decent investor interest, achieving an overall oversubscription of 3.3 times, driven largely by strong participation from NIIs
Investors can check their Om Power Transmission IPO allotment status on the official NSE and BSE websites, as well as on the registrar's portal, MUFG Intime India
Amir Chand Jagdish Kumar stock began its maiden trading session on the BSE at ₹195, reflecting a discount of ₹17, or 8.02 per cent, from its IPO issue price of ₹212 per share
Powerica IPO allotment today: Following the finalisation of the allotment, investors can check the Powerica IPO allotment status on the official websites of BSE, NSE, or MUFG Intime India
Sai Parenteral's IPO allotment status: Once the allotment is finalised, applicants can verify their allotment status online through the websites of the BSE, NSE, and Bigshare Services
Investors who have applied for the Amir Chand IPO can check the share allotment status on the official BSE or NSE websites, or on the website of Kfin Technologies, the registrar for the issue
Central Mine Planning raised ₹1,842.12 crore through its initial public offering (IPO), which comprises an offer for sale (OFS) of 107.1 million equity shares.
Among the three IPOs set to close for subscription today, only Amir Chand Jagdish Kumar has been fully subscribed, while Powerica, and Sai Parenteral's are yet to be fully booked